These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16371317)

  • 1. Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retinal degeneration.
    Babai N; Atlasz T; Tamás A; Reglödi D; Tóth G; Kiss P; Gábriel R
    Neurotox Res; 2005 Nov; 8(3-4):227-33. PubMed ID: 16371317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration.
    Atlasz T; Szabadfi K; Kiss P; Babai N; Koszegi Z; Tamas A; Reglodi D; Gabriel R
    J Mol Neurosci; 2008 Nov; 36(1-3):97-104. PubMed ID: 18418735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate.
    Tamás A; Gábriel R; Rácz B; Dénes V; Kiss P; Lubics A; Lengvári I; Reglodi D
    Neurosci Lett; 2004 Nov; 372(1-2):110-3. PubMed ID: 15531098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pituitary adenylate cyclase activating polypeptide and its fragments on retinal degeneration induced by neonatal monosodium glutamate treatment.
    Atlasz T; Szabadfi K; Reglodi D; Kiss P; Tamás A; Tóth G; Molnár A; Szabó K; Gábriel R
    Ann N Y Acad Sci; 2009 Apr; 1163():348-52. PubMed ID: 19456357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PACAP improves functional outcome in excitotoxic retinal lesion: an electroretinographic study.
    Varga B; Szabadfi K; Kiss P; Fabian E; Tamas A; Griecs M; Gabriel R; Reglodi D; Kemeny-Beke A; Pamer Z; Biro Z; Tosaki A; Atlasz T; Juhasz B
    J Mol Neurosci; 2011 Jan; 43(1):44-50. PubMed ID: 20567936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of systemic PACAP treatment in monosodium glutamate-induced behavioral changes and retinal degeneration.
    Kiss P; Tamás A; Lubics A; Lengvári I; Szalai M; Hauser D; Horvath ZS; Racz B; Gabriel R; Babai N; Toth G; Reglódi D
    Ann N Y Acad Sci; 2006 Jul; 1070():365-70. PubMed ID: 16888193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.
    Atlasz T; Szabadfi K; Kiss P; Tamas A; Toth G; Reglodi D; Gabriel R
    Brain Res Bull; 2010 Mar; 81(4-5):497-504. PubMed ID: 19751807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between PACAP- and enriched environment-induced retinal protection in MSG-treated newborn rats.
    Kiss P; Atlasz T; Szabadfi K; Horvath G; Griecs M; Farkas J; Matkovits A; Toth G; Lubics A; Tamas A; Gabriel R; Reglodi D
    Neurosci Lett; 2011 Jan; 487(3):400-5. PubMed ID: 21050880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for the optimal monosodium glutamate treatment schedule to study the neuroprotective effects of PACAP in the retina.
    Babai N; Atlasz T; Tamás A; Reglodi D; Tóth G; Kiss P; Gábriel R
    Ann N Y Acad Sci; 2006 Jul; 1070():149-55. PubMed ID: 16888157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of PACAP in UV-A radiation-induced retinal degeneration models in rats.
    Atlasz T; Szabadfi K; Kiss P; Marton Z; Griecs M; Hamza L; Gaal V; Biro Z; Tamas A; Hild G; Nyitrai M; Toth G; Reglodi D; Gabriel R
    J Mol Neurosci; 2011 Jan; 43(1):51-7. PubMed ID: 20521124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats.
    Atlasz T; Babai N; Kiss P; Reglodi D; Tamás A; Szabadfi K; Tóth G; Hegyi O; Lubics A; Gábriel R
    Gen Comp Endocrinol; 2007; 153(1-3):108-14. PubMed ID: 17289046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration.
    Szabadfi K; Danyadi B; Kiss P; Tamas A; Fabian E; Gabriel R; Reglodi D
    J Mol Neurosci; 2012 Nov; 48(3):501-7. PubMed ID: 22544514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats.
    Rácz B; Gallyas F; Kiss P; Tamás A; Lubics A; Lengvári I; Röth E; Tóth G; Hegyi O; Verzál Z; Fabricsek C; Reglódi D
    Neurotox Res; 2007 Sep; 12(2):95-104. PubMed ID: 17967733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways.
    Rácz B; Gallyas F; Kiss P; Tóth G; Hegyi O; Gasz B; Borsiczky B; Ferencz A; Roth E; Tamás A; Lengvári I; Lubics A; Reglodi D
    Regul Pept; 2006 Nov; 137(1-2):20-6. PubMed ID: 16945433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.
    Vaczy A; Reglodi D; Somoskeoy T; Kovacs K; Lokos E; Szabo E; Tamas A; Atlasz T
    J Mol Neurosci; 2016 Oct; 60(2):186-94. PubMed ID: 27566170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocortin 2 treatment is protective in excitotoxic retinal degeneration.
    Szabadfi K; Kiss P; Reglodi D; Fekete EM; Tamas A; Danyadi B; Atlasz T; Gabriel R
    Acta Physiol Hung; 2014 Mar; 101(1):67-76. PubMed ID: 24311224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.
    Szabadfi K; Atlasz T; Kiss P; Danyadi B; Tamas A; Helyes Z; Hashimoto H; Shintani N; Baba A; Toth G; Gabriel R; Reglodi D
    Neurotox Res; 2012 Jan; 21(1):41-8. PubMed ID: 21717232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early postnatal enriched environment decreases retinal degeneration induced by monosodium glutamate treatment in rats.
    Szabadfi K; Atlasz T; Horváth G; Kiss P; Hamza L; Farkas J; Tamás A; Lubics A; Gábriel R; Reglodi D
    Brain Res; 2009 Mar; 1259():107-12. PubMed ID: 19171125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.
    Szabadfi K; Reglodi D; Szabo A; Szalontai B; Valasek A; Setalo G; Kiss P; Tamas A; Wilhelm M; Gabriel R
    Neurotox Res; 2016 Apr; 29(3):432-46. PubMed ID: 26739825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diazoxide is protective in the rat retina against ischemic injury induced by bilateral carotid occlusion and glutamate-induced degeneration.
    Atlasz T; Babai N; Reglodi D; Kiss P; Tamas A; Bari F; Domoki F; Gabriel R
    Neurotox Res; 2007 Sep; 12(2):105-11. PubMed ID: 17967734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.